The association between cancer family history and ovarian cancer risk in BRCA1/2 mutation carriers: can it be explained by the mutation position?

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

(2017) Karoline B. Kuchenbaecker et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers

(2017) Karoline B Kuchenbaecker et al.   JNCI-Journal of the National Cancer Institute

Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers

(2017) Karoline B Kuchenbaecker et al.   JNCI-Journal of the National Cancer Institute

Modifiers of breast and ovarian cancer risks forBRCA1andBRCA2mutation carriers

(2016) Roger L Milne et al.   ENDOCRINE-RELATED CANCER

Validation of Family Cancer History Data in High-Risk Families: The Influence of Cancer Site, Ethnicity, Kinship Degree, and Multiple Family Reporters

(2015) P. Tehranifar et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Long-term health consequences of premature or early menopause and considerations for management

(2015) S. S. Faubion et al.   CLIMACTERIC

Association of Type and Location ofBRCA1andBRCA2Mutations With Risk of Breast and Ovarian Cancer

(2015) Timothy R. Rebbeck et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Bias Correction Methods Explain Much of the Variation Seen in Breast Cancer Risks ofBRCA1/2Mutation Carriers

(2015) Janet R. Vos et al.   JOURNAL OF CLINICAL ONCOLOGY

Ovarian cancer in BRCA1/2 mutation carriers: The impact of mutation position and family history on the cancer risk

(2015) Natalia Teixeira et al.   MATURITAS

Identification of six new susceptibility loci for invasive epithelial ovarian cancer

(2015) Karoline B Kuchenbaecker et al.   NATURE GENETICS

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

(2014) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Modifiers of Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: A Systematic Review and Meta-Analysis

(2014) Tara M. Friebel et al.   JNCI-Journal of the National Cancer Institute

Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations

(2013) Richard M Brohet et al.   JOURNAL OF MEDICAL GENETICS

Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE

(2013) Nasim Mavaddat et al.   JNCI-Journal of the National Cancer Institute

Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

(2013) Fergus J. Couch et al.   PLoS Genetics

Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing

(2011) T. Walsh et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Family History of Cancer and Cancer Risks in Women with BRCA1 or BRCA2 Mutations

(2010) K. Metcalfe et al.   JNCI-Journal of the National Cancer Institute

Risk of ovarian cancer in women with first-degree relatives with cancer

(2009) Marie Soegaard et al.   ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA

Physical activity and the risk of breast cancer in BRCA1/2 mutation carriers

(2009) Anouk Pijpe et al.   BREAST CANCER RESEARCH AND TREATMENT

Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers

(2009) T. R. Rebbeck et al.   JNCI-Journal of the National Cancer Institute